Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumors.
Saved in:
| Title: | Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumors. |
|---|---|
| Authors: | Kummar S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA., Chen A; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA., Gutierrez M; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA., Pfister TD; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Wang L; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Redon C; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Bonner WM; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Yutzy W; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Zhang Y; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Kinders RJ; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Ji J; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Allen D; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA., Covey JM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA., Eiseman JL; Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA., Holleran JL; Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA., Beumer JH; Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA., Rubinstein L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA., Collins J; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA., Tomaszewski J; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA., Parchment R; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Pommier Y; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA. doroshoj@mail.nih.gov.; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. doroshoj@mail.nih.gov. |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2016 Jul; Vol. 78 (1), pp. 73-81. Date of Electronic Publication: 2016 May 11. |
| Publication Type: | Comparative Study; Controlled Clinical Trial; Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27169793 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kummar+S%22">Kummar S</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA.<br /><searchLink fieldCode="AU" term="%22Chen+A%22">Chen A</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA.<br /><searchLink fieldCode="AU" term="%22Gutierrez+M%22">Gutierrez M</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA.<br /><searchLink fieldCode="AU" term="%22Pfister+TD%22">Pfister TD</searchLink>; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Redon+C%22">Redon C</searchLink>; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Bonner+WM%22">Bonner WM</searchLink>; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Yutzy+W%22">Yutzy W</searchLink>; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Kinders+RJ%22">Kinders RJ</searchLink>; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Ji+J%22">Ji J</searchLink>; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Allen+D%22">Allen D</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA.<br /><searchLink fieldCode="AU" term="%22Covey+JM%22">Covey JM</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA.<br /><searchLink fieldCode="AU" term="%22Eiseman+JL%22">Eiseman JL</searchLink>; Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Holleran+JL%22">Holleran JL</searchLink>; Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Beumer+JH%22">Beumer JH</searchLink>; Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Rubinstein+L%22">Rubinstein L</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA.<br /><searchLink fieldCode="AU" term="%22Collins+J%22">Collins J</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA.<br /><searchLink fieldCode="AU" term="%22Tomaszewski+J%22">Tomaszewski J</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA.<br /><searchLink fieldCode="AU" term="%22Parchment+R%22">Parchment R</searchLink>; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Pommier+Y%22">Pommier Y</searchLink>; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Doroshow+JH%22">Doroshow JH</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 31 Center Drive, Room 3A44, Bethesda, MD, 20814, USA. doroshoj@mail.nih.gov.; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. doroshoj@mail.nih.gov. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227806519%22">Cancer chemotherapy and pharmacology</searchLink> [Cancer Chemother Pharmacol] 2016 Jul; Vol. 78 (1), pp. 73-81. <i>Date of Electronic Publication: </i>2016 May 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Comparative Study; Controlled Clinical Trial; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7806519 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0843 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203445704%22">03445704 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Chemother Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27169793 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00280-016-2998-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 73 Titles: – TitleFull: Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kummar S – PersonEntity: Name: NameFull: Chen A – PersonEntity: Name: NameFull: Gutierrez M – PersonEntity: Name: NameFull: Pfister TD – PersonEntity: Name: NameFull: Wang L – PersonEntity: Name: NameFull: Redon C – PersonEntity: Name: NameFull: Bonner WM – PersonEntity: Name: NameFull: Yutzy W – PersonEntity: Name: NameFull: Zhang Y – PersonEntity: Name: NameFull: Kinders RJ – PersonEntity: Name: NameFull: Ji J – PersonEntity: Name: NameFull: Allen D – PersonEntity: Name: NameFull: Covey JM – PersonEntity: Name: NameFull: Eiseman JL – PersonEntity: Name: NameFull: Holleran JL – PersonEntity: Name: NameFull: Beumer JH – PersonEntity: Name: NameFull: Rubinstein L – PersonEntity: Name: NameFull: Collins J – PersonEntity: Name: NameFull: Tomaszewski J – PersonEntity: Name: NameFull: Parchment R – PersonEntity: Name: NameFull: Pommier Y – PersonEntity: Name: NameFull: Doroshow JH IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2016 Jul Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1432-0843 Numbering: – Type: volume Value: 78 – Type: issue Value: 1 Titles: – TitleFull: Cancer chemotherapy and pharmacology Type: main |
| ResultId | 1 |
